Induction of Ram Bone Marrow Mesenchymal Stem Cells into Germ Cell Lineage using Transforming Growth Factor-β Superfamily Growth Factors

2014 ◽  
Vol 49 (4) ◽  
pp. 588-598 ◽  
Author(s):  
M Ghasemzadeh-Hasankolaei ◽  
MA Sedighi-Gilani ◽  
MB Eslaminejad
2020 ◽  
Vol 15 (2) ◽  
pp. 1261-1275 ◽  
Author(s):  
Mudasir Bashir Gugjoo ◽  
Amarpal ◽  
Ahmed Abdelbaset-Ismail ◽  
Hari Prasad Aithal ◽  
Prakash Kinjavdekar ◽  
...  

Aim: An attempt was made to improve osteochondral healing with allogeneic mesenchymal stem cells (MSCs) along with certain growth factors. Materials & methods: Induced knee osteochondral defects were filled as: phosphate buffer saline (group A); MSCs in collagen gel (group B); group B plus insulin like growth factor-1 (group C); group C plus transforming growth factor β-1 (group D). Results: Gross and scanning electron microscopy showed superior morphology and surface architecture of the healed tissue in groups D and C. Histologically, group D revealed hyaline cartilage characteristic features followed in order by group C and group B. In all treatment groups, chondrogenic matrix, collagen II2B ( col II 2B) and aggrecan were secreted. Conclusion: Combined use of MSCs and growth factors could accelerate osteochondral healing.


2004 ◽  
Vol 279 (42) ◽  
pp. 43725-43734 ◽  
Author(s):  
Daojing Wang ◽  
Jennifer S. Park ◽  
Julia S. F. Chu ◽  
Ari Krakowski ◽  
Kunxin Luo ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-11 ◽  
Author(s):  
Shutian Shi ◽  
Xingxin Wu ◽  
Xiao Wang ◽  
Wen Hao ◽  
Huangtai Miao ◽  
...  

Bone marrow mesenchymal stem cells (BMMSCs) are used in cardiac tissue engineering for the regeneration of diseased hearts. We examined the differentiation of rat BMMSCs into cardiomyocyte-like cells when induced with a combined low dose treatment of transforming growth factor-β1 (TGF-β1) and 5-azacytidine (5-AZA). Results showed that cell proliferation in the combined low dose treatment group of TGF-β1 and 5-AZA was increased compared with the TGF-β1 group or the 5-AZA group. The cell apoptosis was relieved by combined TGF-β1 and 5-AZA treatment compared to 5-AZA treatment alone. The number of cells positive for myosin heavy chain, connexin-43,α-actin, and troponin I in the combined treatment group was higher than those observed in the TGF-β1 group or the 5-AZA group. Moreover, the combined low dose treatment group of TGF-β1 and 5-AZA reveals the strongest expression of troponin I,α-actin, and phosphorylated extracellular signal-regulated protein kinases 1 and 2 (p-ErK1/2) among the treatment groups. These results suggest that the combined low dose treatment of TGF-β1 and 5-AZA can improve the differentiation potential of rat BMMSCs into cardiomyocyte-like cells and alleviate cell damage effectsin vitro. The mechanism that is involved in influencing differentiation may be associated with p-ErK1/2.


Sign in / Sign up

Export Citation Format

Share Document